Market Tracker

01/17 4:45pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.10
Delayed Data
As of Jan 17
 +0.10 / +3.33%
Today’s Change
1.62
Today|||52-Week Range
5.79
+16.10%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.00
Today’s open3.10
Day’s range3.01 - 3.10
Volume75,695
Average volume (3 months)415,074
Market cap$143.6M
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.11-1.40%
REPHRecro Pharma Inc-0.40-5.33%
GLYCGlycoMimetics Inc-0.13-2.12%
EGLTEgalet Corp-0.56-9.49%
Data as of 4:00pm ET, 01/17/2017

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer &
Secretary
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts